Literature DB >> 25825738

Autoinhibition of MDMX by intramolecular p53 mimicry.

Lihong Chen1, Wade Borcherds2, Shaofang Wu1, Andreas Becker3, Ernst Schonbrunn4, Gary W Daughdrill2, Jiandong Chen5.   

Abstract

The p53 inhibitor MDMX is controlled by multiple stress signaling pathways. Using a proteolytic fragment release (PFR) assay, we detected an intramolecular interaction in MDMX that mechanistically mimics the interaction with p53, resulting in autoinhibition of MDMX. This mimicry is mediated by a hydrophobic peptide located in a long disordered central segment of MDMX that has sequence similarity to the p53 transactivation domain. NMR spectroscopy was used to show this hydrophobic peptide interacts with the N-terminal domain of MDMX in a structurally analogous manner to p53. Mutation of two critical tryptophan residues in the hydrophobic peptide disrupted the intramolecular interaction and increased p53 binding, providing further evidence for mechanistic mimicry. The PFR assay also revealed a second intramolecular interaction between the RING domain and central region that regulates MDMX nuclear import. These results establish the importance of intramolecular interactions in MDMX regulation, and validate a new assay for the study of intramolecular interactions in multidomain proteins with intrinsically disordered regions.

Entities:  

Keywords:  MDMX; acidic domain; intramolecular; p53; protease

Mesh:

Substances:

Year:  2015        PMID: 25825738      PMCID: PMC4403185          DOI: 10.1073/pnas.1420833112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  DNA damage-induced MDMX degradation is mediated by MDM2.

Authors:  Hidehiko Kawai; Dmitri Wiederschain; Hiroyuki Kitao; Jeremy Stuart; Kelvin K C Tsai; Zhi-Min Yuan
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

2.  MDM4 binds ligands via a mechanism in which disordered regions become structured.

Authors:  Maria C Sanchez; Jonathan G Renshaw; Gareth Davies; Paul N Barlow; Martin Vogtherr
Journal:  FEBS Lett       Date:  2010-05-31       Impact factor: 4.124

3.  Regulation of p53-MDMX interaction by casein kinase 1 alpha.

Authors:  Lihong Chen; Changgong Li; Yu Pan; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

4.  Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.

Authors:  Cynthia LeBron; Lihong Chen; Daniele M Gilkes; Jiandong Chen
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

5.  Mapping of the p53 and mdm-2 interaction domains.

Authors:  J Chen; V Marechal; A J Levine
Journal:  Mol Cell Biol       Date:  1993-07       Impact factor: 4.272

6.  Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization.

Authors:  Bradford Graves; Thelma Thompson; Mingxuan Xia; Cheryl Janson; Christine Lukacs; Dayanand Deo; Paola Di Lello; David Fry; Colin Garvie; Kuo-Sen Huang; Lin Gao; Christian Tovar; Allen Lovey; Jutta Wanner; Lyubomir T Vassilev
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-28       Impact factor: 11.205

7.  Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development.

Authors:  Tamara Terzian; Yongxing Wang; Carolyn S Van Pelt; Neil F Box; Elisabeth L Travis; Guillermina Lozano
Journal:  Mol Cell Biol       Date:  2007-05-25       Impact factor: 4.272

8.  Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.

Authors:  Yong S Chang; Bradford Graves; Vincent Guerlavais; Christian Tovar; Kathryn Packman; Kwong-Him To; Karen A Olson; Kamala Kesavan; Pranoti Gangurde; Aditi Mukherjee; Theresa Baker; Krzysztof Darlak; Carl Elkin; Zoran Filipovic; Farooq Z Qureshi; Hongliang Cai; Pamela Berry; Eric Feyfant; Xiangguo E Shi; James Horstick; D Allen Annis; Anthony M Manning; Nader Fotouhi; Huw Nash; Lyubomir T Vassilev; Tomi K Sawyer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-14       Impact factor: 11.205

Review 9.  Structural and energetic basis of allostery.

Authors:  Vincent J Hilser; James O Wrabl; Hesam N Motlagh
Journal:  Annu Rev Biophys       Date:  2012       Impact factor: 12.981

10.  Abnormal MDMX degradation in tumor cells due to ARF deficiency.

Authors:  X Li; D Gilkes; B Li; Q Cheng; D Pernazza; H Lawrence; N Lawrence; J Chen
Journal:  Oncogene       Date:  2011-11-28       Impact factor: 9.867

View more
  20 in total

1.  Interaction between p53 N terminus and core domain regulates specific and nonspecific DNA binding.

Authors:  Fan He; Wade Borcherds; Tanjing Song; Xi Wei; Mousumi Das; Lihong Chen; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-15       Impact factor: 11.205

2.  Optimal Affinity Enhancement by a Conserved Flexible Linker Controls p53 Mimicry in MdmX.

Authors:  Wade Borcherds; Andreas Becker; Lihong Chen; Jiandong Chen; Lucía B Chemes; Gary W Daughdrill
Journal:  Biophys J       Date:  2017-05-06       Impact factor: 4.033

3.  Using NMR Chemical Shifts to Determine Residue-Specific Secondary Structure Populations for Intrinsically Disordered Proteins.

Authors:  Wade M Borcherds; Gary W Daughdrill
Journal:  Methods Enzymol       Date:  2018-10-22       Impact factor: 1.600

4.  Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.

Authors:  Xi Wei; Shaofang Wu; Tanjing Song; Lihong Chen; Ming Gao; Wade Borcherds; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

Review 5.  Functional advantages of dynamic protein disorder.

Authors:  Rebecca B Berlow; H Jane Dyson; Peter E Wright
Journal:  FEBS Lett       Date:  2015-06-11       Impact factor: 4.124

6.  Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.

Authors:  Leixiang Yang; Tanjing Song; Qian Cheng; Lihong Chen; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2019-02-04       Impact factor: 4.272

7.  MDMX acidic domain inhibits p53 DNA binding in vivo and regulates tumorigenesis.

Authors:  Qingling Huang; Lihong Chen; Leixiang Yang; Xiaoling Xie; Lin Gan; John L Cleveland; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

8.  MDMX inhibits casein kinase 1α activity and stimulates Wnt signaling.

Authors:  Qingling Huang; Lihong Chen; Ernst Schonbrunn; Jiandong Chen
Journal:  EMBO J       Date:  2020-06-08       Impact factor: 11.598

Review 9.  MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.

Authors:  Jean-Christophe Marine; Aart G Jochemsen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

Review 10.  MDM2 oligomers: antagonizers of the guardian of the genome.

Authors:  P L Leslie; Y Zhang
Journal:  Oncogene       Date:  2016-04-04       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.